Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Pharmacotherapy
|
September 22, 2000
Hormone replacement therapy should not be used as secondary prevention of coronary heart disease
M M Barbour
Medicine and Health, Rhode Island
|
March 29, 2001
Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes
M M Barbour, A Zuwallack
Seminars in Nephrology
|
February 15, 2001
Pharmacology and pharmacotherapy of cardiovascular drugs in patients with chronic renal disease
M M Barbour, D S McKindley
Plant, Cell & Environment
|
October 15, 2016
Leaf water stable isotopes and water transport outside the xylem
M M Barbour, G D Farquhar, T N Buckley
Pharmacotherapy
|
May 20, 1999
Antiischemic therapy in patients with coronary heart disease living in long-term care. Systematic Assessment of Geriatric Drug Use by Epidemiology (SAGE) Group
K L Lapane, M M Barbour, A Van Haaren, et al.
Pharmacotherapy
|
May 1, 1993
The drug data base of the Pawtucket Heart Health Program: development and description
M M Barbour, A L Hume, A R Assaf, et al.
Journal of the American College of Cardiology
|
July 1, 1994
The ischemic threshold does vary under differing exercise conditions
C E Garber, G V Heller, M M Barbour, et al.
Pharmacotherapy
|
June 13, 2001
Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort
C A Derby, M M Barbour, A L Hume, et al.
Pharmacotherapy
|
January 1, 1995
Is antidepressant use changing? Prevalence and clinical correlates in two New England communities
A L Hume, M M Barbour, K L Lapane, et al.
The American Journal of Cardiology
|
September 1, 1991
Comparison of chest pain, electrocardiographic changes and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris
G V Heller, I Ahmed, P L Tilkemeier, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Pharmacotherapy
|
September 22, 2000
Hormone replacement therapy should not be used as secondary prevention of coronary heart disease
M M Barbour
Medicine and Health, Rhode Island
|
March 29, 2001
Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes
M M Barbour, A Zuwallack
Seminars in Nephrology
|
February 15, 2001
Pharmacology and pharmacotherapy of cardiovascular drugs in patients with chronic renal disease
M M Barbour, D S McKindley
Plant, Cell & Environment
|
October 15, 2016
Leaf water stable isotopes and water transport outside the xylem
M M Barbour, G D Farquhar, T N Buckley
Pharmacotherapy
|
May 20, 1999
Antiischemic therapy in patients with coronary heart disease living in long-term care. Systematic Assessment of Geriatric Drug Use by Epidemiology (SAGE) Group
K L Lapane, M M Barbour, A Van Haaren, et al.
Pharmacotherapy
|
May 1, 1993
The drug data base of the Pawtucket Heart Health Program: development and description
M M Barbour, A L Hume, A R Assaf, et al.
Journal of the American College of Cardiology
|
July 1, 1994
The ischemic threshold does vary under differing exercise conditions
C E Garber, G V Heller, M M Barbour, et al.
Pharmacotherapy
|
June 13, 2001
Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort
C A Derby, M M Barbour, A L Hume, et al.
Pharmacotherapy
|
January 1, 1995
Is antidepressant use changing? Prevalence and clinical correlates in two New England communities
A L Hume, M M Barbour, K L Lapane, et al.
The American Journal of Cardiology
|
September 1, 1991
Comparison of chest pain, electrocardiographic changes and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris
G V Heller, I Ahmed, P L Tilkemeier, et al.
Page
of 3